Rare Lipid Disorders
- Genetic causes of Hypertriglyceridemia (HTG) such as Lipoprotein Lipase (LPL) Deficiency should be considered in severe HTG cases where multiple drug Pharmacotherapy and aggressive dietary modifications fail to optimize Triglyceride (TG) levels.
- Recognition of a genetic basis of HTG is beneficial in:
- Understanding the reason for failed management
- Reassuring the patient as well as the clinician
- Affected family members can be screened and treated prior to having acute complications.
- Some cases with severe HTG will Necessitate using new drugs such as Volanesorsen.
Dr. Devaki R Nair
Dr. Devaki R Nair is a Consultant Chemical Pathologist and Clinical Lead for Clinical biochemistry Royal Free hospital and North Middlesex University Hospital. She is Completed BSc MSc MBBS FRCP FRCPath and Director SAS Centre for Cardiovascular Biomarkers, Training Programme Director for Chemical Pathology and Metabolic Medicine; Speciality Lead for Biochemistry HSL. She is involved in conducting many clinical trials for novel lipid-lowering drugs as chief investigator and as principal investigator. She set up one of the first family support centre for FH and was awarded a BHF grant for cascade testing.
More FAQs by Dr. Devaki R Nair
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article